Skip to main content
. 2017 May 20;10(5):559. doi: 10.3390/ma10050559

Figure 2.

Figure 2

The influence of doxorubicin and polyhedral oligomeric silsesquioxanes co-delivered at different molar ratios on cell viability (A) of human breast adenocarcinoma (MCF-7), (B) microvascular endothelial (HMEC-1), and (C) human cervical cancer endothelial (HeLa) cell lines. Data are presented as a percentage of control ± SD, * p < 0.05 (statistical significance between DOX and POSS:DOX complexes).